非布司他治疗痛风患者效果好吗？

Is it effective in treating gout patients? This is a question that many patients have mentioned recently. Let’s take a look at it below. Febuxostat is a new type of drug that inhibits uric acid production and has a strong uric acid-lowering effect. The effect of one tablet of febuxostat is about the same as that of three tablets of allopurinol. The occurrence of allergic reactions is significantly reduced, the medication is safe, and there are basically no fatal allergic reactions. And because it is metabolized by the liver, patients with impaired kidney function do not need to adjust their medication. Because it inhibits the production of uric acid from the beginning and does not increase the burden on the kidneys, patients with urinary tract stones can also use it with confidence. Therefore, it is currently the first choice for clinical urate-lowering drugs.

Febuxostat is very effective in reducing uric acid in the human body, and the effect is very fast. After taking Febuxostat, uric acid can be reduced to an ideal value. When using febuxostat to reduce uric acid in the human body, the dosage can be appropriately reduced according to the specific situation. However, it must be reduced under the guidance and supervision of a doctor, and it cannot be increased or decreased without permission, otherwise it will cause great harm to the body.  

At present, uric acid-lowering drugs are divided into two categories: one is a drug that promotes uric acid excretion. Its function is to promote the kidneys to "run fast" and increase the excretion of uric acid. The representative drug is "benbromarone". Unfortunately, gout itself can cause renal insufficiency. Because this drug causes the kidneys to "run fast" and may worsen the already poor kidney function, medical guidelines in various countries do not recommend it as the first choice. The other type is drugs that inhibit the production of uric acid. They can directly inhibit the production of uric acid in the body without increasing the burden on the kidneys. They are the drugs recommended by the guidelines of various countries. There are currently two types of this drug: allopurinol and febuxostat. Allopurinol is cheap, has been used for many years, and has good efficacy in some patients. Unfortunately, because many Asians carry the HLA-B5801 gene, the incidence of allergy to allopurinol is higher, and allopurinol can cause serious adverse reactions - STEVE JOHNSON syndrome, which can lead to death in some severe patients. Medical disputes caused by this drug are common. Therefore, the drug is relatively dangerous and its application in China has been restricted. 

The above is the effect of febuxostat in the treatment of gout provided by our medical companion travel overseas medical consulting service company. From this point of view, the effect of treating gout is still very ideal.